target_chembl_id,target_organism,document_journal,document_year,activity_id,standard_type,molecule_pref_name,target_pref_name,assay_chembl_id,bao_format,pchembl_value,assay_description
CHEMBL372,Homo sapiens,Bioorg. Med. Chem. Lett.,1999,228100,IC50,CRYPTOPHYCIN 52,Homo sapiens,CHEMBL695988,BAO_0000218,9.7,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).
CHEMBL382,Homo sapiens,Bioorg. Med. Chem. Lett.,1999,607689,IC50,CRYPTOPHYCIN 52,CCRF-CEM,CHEMBL656081,BAO_0000219,10.7,In vitro cytotoxicity against human leukemia CCRF-CEM cell line
CHEMBL382,Homo sapiens,J. Med. Chem.,2003,687324,IC50,CRYPTOPHYCIN 52,CCRF-CEM,CHEMBL856074,BAO_0000219,10.66,In vitro growth inhibitory activity in the human CCRF-CEM leukemia cell line.
CHEMBL3879801,None,J. Med. Chem.,2013,12654486,IC50,CRYPTOPHYCIN 52,NON-PROTEIN TARGET,CHEMBL2327777,BAO_0000219,9.59,Cytotoxicity against human KBV1 cells by resazurin reduction assay
CHEMBL3879801,None,J. Med. Chem.,2013,12654500,IC50,CRYPTOPHYCIN 52,NON-PROTEIN TARGET,CHEMBL2327778,BAO_0000219,10.81,Cytotoxicity against human KB-3-1 cells by resazurin reduction assay
